10 transactions in 2 companies, from February 4, 2026 to July 8, 2026.
Where this insider traded.
| Company | Ticker | Trades | Bought | Sold |
|---|---|---|---|---|
| Syndax Pharmaceuticals Inc | SNDX | 9 | — | $1.4M |
| Pyxis Oncology, Inc. | PYXS | 1 | — | — |
10 in total, newest filings first.
| Company | Ticker | Insider | Date | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|---|
| Syndax Pharmaceuticals Inc | SNDX | Michael A. MetzgerCEODERIV | Jul 8 | MPLAN | 32,375 | $0.00 | —? |
| Syndax Pharmaceuticals Inc | SNDX | Michael A. MetzgerCEO | Jul 8 | SPLAN | 32,375 | $24.24 | $785K |
| Syndax Pharmaceuticals Inc | SNDX | Michael A. MetzgerCEO | Jul 8 | MPLAN | 32,375 | $6.38 | $207K |
| Syndax Pharmaceuticals Inc | SNDX | Michael A. MetzgerCEO | Jun 1 | S | 6,847 | $18.99 | $130K |
| Pyxis Oncology, Inc. | PYXS | Michael A. MetzgerDirDERIV | Mar 24 | A | 45,867 | $0.00 | —? |
| Syndax Pharmaceuticals Inc | SNDX | Michael A. MetzgerCEO | Feb 9 | S | 17,159 | $21.03 | $361K |
| Syndax Pharmaceuticals Inc | SNDX | Michael A. MetzgerCEODERIV | Feb 4 | A | 440,000 | $20.43 | $9.0M? |
| Syndax Pharmaceuticals Inc | SNDX | Michael A. MetzgerCEO | Feb 6 | S | 7,412 | $20.62 | $153K |
| Syndax Pharmaceuticals Inc | SNDX | Michael A. MetzgerCEO | Feb 4 | A | 144,600 | $0.00 | — |
| Syndax Pharmaceuticals Inc | SNDX | Michael A. MetzgerCEO | Feb 4 | A | 73,000 | $0.00 | — |